Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Brazil updates medtech GMP (good manufacturing practice) and QC (quality control) list:

This article was originally published in Clinica

Executive Summary

Brazil's healthcare surveillance agency, Anvisa, has updated the list of medical technology companies awarded a certificate for good practice in manufacturing and controls. Fundacao Fahucam, Polysuture, Johnson & Johnson Industrial, Johnson & Johnson Produtos Profissionais, Siemens, Cmos Drake Do Nordeste, Laboratorios B Braun and Dentsply are among the latest additions, having been approved last month. Some 130 certificates have been issued since December 2000. K Takaoka, Baumer, Silimed (Silicone e Instrumental Medico-Hospitalar), Fanem, Nipro Medical, Biotechnology Ortopedia Importacao/Exportacao and Ortosintese were the first companies to be awarded. The certificates are issued under a legal Resolution and apply for one year from their announcement in the Diario Oficial da Uniao.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT059032

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel